Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Dumbing down HIV treatment hurts everybody

Bob Leahy says there is so much faulty information on what being on treatment means and when to start that it is hurting us all. But there are solutions which can successfully balance patient rights with the benefits of starting treatment early.

Published
11 February 2016
From
Positive Lite
HIV and drug resistance

A recent study found more resistance to the antiretroviral medicine tenofovir than had previously been reported, with 20% resistance to tenofovir in patients with treatment failure in Europe and over 50% resistance in patients with treatment failure in sub-Saharan Africa... The study underlines the importance of rapidly identifying treatment failure through routine measurement of viral load suppression—this is the basis of the third pillar of UNAIDS’ 90–90–90 treatment target, that 90% of people accessing HIV treatment have suppressed viral loads.

Published
09 February 2016
From
UNAIDS
African Americans have highest HIV incidence, lowest rate of consistent care

African Americans in the US have the highest rate of new HIV infections, but black people living with HIV are less likely than white or Latino

Published
08 February 2016
By
Liz Highleyman
Women under-represented in HIV clinical trials

Less than a quarter of people taking part in clinical trials for antiretroviral medications are women, potentially limiting the generalisability of findings, according to a systematic review

Published
08 February 2016
By
Roger Pebody
Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice

A combination of fine-particle formulations of the drugs atazanavir and ritonavir, plus an immune-dampener drug designed to induce cells to keep hold of the drugs for longer,

Published
05 February 2016
By
Gus Cairns
Adenosine deaminase may help the immune system fight HIV on its own

New research published in the Journal of Leukocyte Biology suggests that adenosine deaminase enhances anti-HIV-1 specific immune responses by reducing the action of cells that impede HIV-specific defenses

Published
03 February 2016
From
Eurekalert Medicine & Health
Tenofovir resistance may develop in more than half of patients failing treatment in sub-Saharan Africa

More than half of people who experienced failure of a tenofovir-based antiretroviral regimen in sub-Saharan Africa had resistance to tenofovir, a meta-analysis of drug resistance studies published

Published
01 February 2016
By
Keith Alcorn
US: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

What's New in the Guidelines? Revisions to the April 8, 2015, version of the guidelines are largely based on findings from two large, randomized controlled trials that addressed the optimal time to initiate antiretroviral therapy (ART)—START (Strategic Timing of Antiretroviral Therapy) and TEMPRANO.

Published
01 February 2016
From
AIDS.info
Haitian AIDS Patients' 10-year Survival Equal to American Patients

One of the first groups of AIDS patients to receive free HIV drugs in a public health setting in the developing world is living as long as those in the United States, according to research conducted by Weill Cornell Medicine investigators.

Published
01 February 2016
From
Weill Cornell Medical College
HIV resistance to favored treatment not uncommon

Resistance to a key HIV drug is common worldwide and could mean trouble for treating and preventing the virus that causes AIDS, according to a new study.

Published
29 January 2016
From
Reuters
← First12345...409Next →

Filter by country